Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer (EOC)
Human Pathology Jan 05, 2018
Ojalvo LS, et al. - Experts undertook this study in order to examine the tumor microenvironment (TME) of primary and recurrent epithelial ovarian cancer (EOC). It was reported that the tumor-associated macrophage (TAM) density did not exert an impact on the patient survival. Yet, longer overall survival (OS) from recurrence was revealed in patients with increased TAMs at recurrence (n=5) compared to patients without increased TAMs (n=12) (56.0 vs 20.0 months). It was also deduced that with the small sample size, this did not reach statistical significance. A necessity arose for further characterization of the evolution of the TME.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries